Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes (BEGIN™)
This study has been completed.
Study NCT01079234   Information provided by Novo Nordisk

First Received on March 2, 2010.   Last Updated on December 8, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 1
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
NN1250
insulin glargine
insulin aspart
Additional drug interventions recognized in this trial
Glargine
Insulin
Insulin, Long-Acting
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services